Personalized prediction of EGFR mutation-induced drug resistance in lung cancer
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
EGFR mutation-induced drug resistance has significantly impaired the potency of small molecule tyrosine kinase inhibitors in lung cancer treatment. Computational approaches can provide powerful and efficient techniques in the investigation of drug resistance. In our work, the EGFR mutation feature is characterized by the energy components of binding free energy (concerning the mutant-inhibitor complex), and we combine it with specific personal features for 168 clinical subjects to construct a personalized drug resistance prediction model. The 3D structure of an EGFR mutant is computationally predicted from its protein sequence, after which the dynamics of the bound mutant-inhibitor complex is simulated via AMBER and the binding free energy of the complex is calculated based on the dynamics. The utilization of extreme learning machines and leave-one-out cross-validation promises a successful identification of resistant subjects with high accuracy. Overall, our study demonstrates advantages in the development of personalized medicine/therapy design and innovative drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Yun, C.-H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K.-K., Meyerson, M., & Eck, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709662105 · Cited by 2,118 · cited 1×
“1 age Age of the patient Discrete [0, 4] 2 gender Gender of the patient Discrete [0, 1] 3 smoke Smoking history Discrete [0, 2] 4 PS Performance status Discrete [0, 3] 5 histolog Subtypes of the NSCLC Discrete [1, 7]”
BackgroundActivation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhang, Z., Lee, J. C., Lin, L., Olivas, V., Au, V., LaFramboise, T., Abdel-Rahman, M., Wang, X., Levine, A. D., Rho, J. K., et al. (2012) · Nature Genetics · doi:10.1038/ng.2330 · Cited by 1,224
Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
Greulich, H., Chen, T.-H., Feng, W., Jänne, P. A., Alvarez, J. V., Zappaterra, M., Bulmer, S. E., Frank, D. A., Hahn, W. C., Sellers, W. R., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020313 · Cited by 677 · cited 1×
“10 bra_mets Brain metastasis Discrete [0, 9] 11 susp_ire Suspension of TKIs Discrete [0, 1]”
BackgroundProgram optimization carving for GPU computing
Ryoo, S., Rodrigues, C. I., Stone, S. S., Stratton, J. A., Ueng, S.-Z., Baghsorkhi, S. S., & Hwu, W.-M. W. (2008) · Journal of Parallel and Distributed Computing · doi:10.1016/j.jpdc.2008.05.011 · Cited by 126
Cited by
Artificial Intelligence and Biosensors in Healthcare and Its Clinical Relevance: A Review
(2023) · doi:10.1109/access.2023.3285596 · Cited by 205
Application of Artificial Intelligence in Lung Cancer
Chiu, H.-Y., Chao, H.-S., & Chen, Y.-M. (2022) · Cancers · doi:10.3390/cancers14061370 · Cited by 138
“The combination of different features also helps researchers build predictive models [138,139].”
BackgroundTsigelny, I. F., Wheler, J. J., Greenberg, J. P., Kouznetsova, V. L., Stewart, D. J., Bazhenova, L., & Kurzrock, R. (2015) · Oncotarget · doi:10.18632/oncotarget.3472 · Cited by 30
Machine Learning Applications in Lung Cancer Diagnosis, Treatment and Prognosis
Li, Y., Wu, X., Yang, P., Jiang, G., & Luo, Y. (2022) · arXiv · doi:10.48550/arxiv.2203.02794 · Cited by 2
Metadata
- Authors
- Wang, D. D., Zhou, W., Yan, H., Wong, M., & Lee, V.
- Venue
- Scientific Reports
- Published
- 2013-10-04
- Volume
- 3
- Issue
- 1
- Pages
- 2855-2855
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2134574317
- Cited by
- 54
- References
- 4
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.